GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis

As yet, very few vaccine candidates with activity in animals against Mycobacterium tuberculosis infection have been tested as therapeutic postexposure vaccines. We recently described two pools of mycobacterial proteins with this activity, and here we describe further studies in which four of these p...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Thomas H., Shanley, Crystal A., Guo, Zhimin, Bellgrau, Donald, Rodell, Timothy, Furney, Synthia, Henao-Tamayo, Marcela, Orme, Ian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717186/
https://www.ncbi.nlm.nih.gov/pubmed/29046306
http://dx.doi.org/10.1128/CVI.00245-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717186/
https://www.ncbi.nlm.nih.gov/pubmed/29046306
http://dx.doi.org/10.1128/CVI.00245-17

Ejemplares similares